Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
about
Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.Relative impact of multi-layered genomic data on gene expression phenotypes in serous ovarian tumors.H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma.Molecular signaling pathways that regulate prostate gland development.The developing story of Sprouty and cancer.Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapyIntegrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineageFunctional Epigenetic Analysis of Prostate Carcinoma: A Role for Seryl-tRNA Synthetase?DNA methylation changes in prostate cancer: current developments and future clinical implementation.Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 proteinFibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract.Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progressionInitial report on differential expression of sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines.Aberrant expression of hSef and Sprouty4 in endometrial adenocarcinoma.ERK MAP kinase in G cell cycle progression and cancer.Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells.Sprouty 2 regulates DNA damage-induced apoptosis in Ras-transformed human fibroblasts.Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesisIntermolecular interactions of Sprouty proteins and their implications in development and disease.ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy.Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.Loss of Sprouty2 in human high-grade serous ovarian carcinomas promotes EGF-induced E-cadherin down-regulation and cell invasion.Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines.Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cells.Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer.Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts.Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer.Sprouty2 association with B-Raf is regulated by phosphorylation and kinase conformation.Sprouty4 mRNA variants and protein expressions in breast and lung-derived cells.The role of SMAD3 in the genetic predisposition to papillary thyroid carcinoma.Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients.Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours.Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4.Differential expression of sprouty genes in hepatocellular carcinoma.
P2860
Q30439922-25D2BF1A-6E73-486C-AFFC-C998986143CEQ30755707-AE6C358E-E0CB-4BA9-813A-89B6AC61CF11Q33557802-4A8BB2CC-5A09-463A-84C7-85BFC0A07E20Q33666315-D0198C95-E322-49A5-9BEC-1F0A6B6BBEB9Q33962853-2155B234-F11A-44D6-B0E3-5D6368586A9FQ34016357-6945BBD3-1C30-4D18-AB74-5279FBC973A2Q34208426-FAD3A75C-5260-4A2B-A12B-A6C70436568DQ35623572-45767E1B-40BE-4579-8D5B-8768293A8509Q35636543-3DDC6435-D372-48B6-9762-2EC1531A80F6Q36280143-136EDAB8-D131-4A06-8119-8B7ECF6BA761Q36303720-B757DE68-31AF-4077-AFE0-F4EF657C9BA4Q36303927-80E69064-8DF9-4664-8A3B-1AAADB28CF10Q36454937-44AC4F42-43B4-4AC5-B2D9-0AE1414B9070Q36502806-0DD3C69D-0941-4A93-B927-8E39E1887EF2Q36519437-B154683E-F7DA-4B32-837B-D46B27440F2EQ36675601-D69C0D4B-1DDB-4BBC-A35A-0C680144FD01Q37036474-40279634-596D-4D68-82D6-B0403187ACB0Q37310665-A9698328-87AC-4AE0-81C7-6823E41126EAQ37402776-E53B1FDB-6FC8-43EA-AA37-C3AC0AB57BA4Q37457689-1DAE013A-975E-4E46-BBED-485BE2827D5DQ37849781-2F6C0B63-E6D1-4543-81F8-72F240096D38Q38803572-D71AB3B6-E50B-45CB-81F1-D56C8452A3A5Q38926129-188D9167-B29A-40A0-989E-D3500DD27382Q39036313-1EA2EE0D-CCF5-4648-B846-7847929D6604Q39129630-3C982039-B0AB-4822-B569-4AFF56BF2A80Q39493168-34A26BEB-4E94-4E2F-87CA-B5AF7DFFDDBBQ39700563-2A62E9D9-BB24-43E6-87BF-B90F37C6F187Q40042536-DF1721C3-18DC-4BDB-80D3-04FBEBB84618Q41513194-1ACC1765-E7A1-4FA2-8811-801EFDBEBB42Q41822622-52183703-BD22-4C5E-A1D5-119DCA4F62C6Q42137707-04A3A059-665D-403B-8E64-CDD81AF1834EQ47210518-9FED6F59-0364-4DC7-9F43-5B62AC904DAFQ47936319-25C4141C-DE66-444D-8A88-A617F54BF711Q48095542-DBA99A0C-331F-4C1D-92DA-23D55BD2DEB1Q51021775-349565DA-6014-4316-AB37-E3E48873E71BQ54348091-9646256B-2C9F-4FD2-BAEE-AD771A6286BD
P2860
Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Sprouty4, a suppressor of tumo ...... tion in human prostate cancer.
@ast
Sprouty4, a suppressor of tumo ...... tion in human prostate cancer.
@en
Sprouty4, a suppressor of tumo ...... tion in human prostate cancer.
@nl
type
label
Sprouty4, a suppressor of tumo ...... tion in human prostate cancer.
@ast
Sprouty4, a suppressor of tumo ...... tion in human prostate cancer.
@en
Sprouty4, a suppressor of tumo ...... tion in human prostate cancer.
@nl
prefLabel
Sprouty4, a suppressor of tumo ...... tion in human prostate cancer.
@ast
Sprouty4, a suppressor of tumo ...... tion in human prostate cancer.
@en
Sprouty4, a suppressor of tumo ...... tion in human prostate cancer.
@nl
P2093
P356
P1433
P1476
Sprouty4, a suppressor of tumo ...... tion in human prostate cancer.
@en
P2093
Benjamin Thompson
Bernard Kwabi-Addo
Chengxi Ren
Jianghua Wang
Michael Ittmann
P2860
P304
P356
10.1002/PROS.20353
P577
2006-05-01T00:00:00Z